文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 工程科技 > 电子/电路 > PI3K, FAK pathway migration, and invasion in GbM cells
侵权投诉

PI3K, FAK pathway migration, and invasion in GbM cells

doc.guandang.net

Oncotarget, November, Vol.2, No 11

Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells

Genevieve L. Weber1, Marie-Odile Parat2, Zev A. Binder1, Gary L. Gallia1, Gregory J. Riggins1

1 2

Ludwig Collaborative Laboratory, Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD

School of Pharmacy, University of Queensland, Australia

Correspondence to: Gregory J. Riggins, email: griggin1@jhmi.eduKeywords: glioblastoma, PIK3CA, PIK3R1, invasion, PI3K, pathway analysis

Received: October 27, 2011, Accepted: October 28, 2011, Published: November 5, 2011

Copyright: © Weber et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

AbstrAct:

Glioblastoma multiforme (GBM) is a highly invasive and deadly brain tumor. Tumor cell invasion makes complete surgical resection impossible and reduces the efficacy of other therapies. Genome-wide analyses of mutations, copy-number changes, and expression patterns have provided new insights into genetic abnormalities common in GBM. We analyzed published data and identified the invasion and motility pathways most frequently altered in GBM. These were most notably the focal adhesion and integrin signaling, and extracellular matrix interactions pathways. We mapped alterations in each of these pathways and found that they included the catalytic PIK3CA and regulatory PIK3R1 subunit genes of the class IA PI3K. Knockdown of either of these genes separately in GBM cell lines by lentiviral-mediated shRNA expression resulted in decreased proliferation, migration, and invasion in all lines tested. FAK activity was reduced by knockdown of either PIK3CA or PIK3R1, and MMP2 levels were reduced by knockdown of PIK3R1. We conclude that PIK3R1, like PIK3CA, is a potential therapeutic target in GBM and that it also influences tumor cell growth and motility.

INtrODUctION

Glioblastoma multiforme is the most common primary brain malignancy, with a current median survival of approximately 15 months in patients with newly diagnosed disease following treatment with surgery, chemotherapy and radiotherapy [1]. The invasive nature of GBM has been frequently implicated as a key feature of GBM’s resistance to therapy [2-5]. Targeting pathways involved in the invasive phenotype of the tumor could be an important component of successful treatment in combination with strategies that more directly target the cancer cells.

The sequencing of 20,661 gene coding regions in multiple glioblastoma tumors was a significant milestone in understanding the genetic basis of GBM [6]. In this analysis, Parsons, et al utilized automated sequencing approaches and Illumina SNP arrays to identify mutations and copy number changes, respectively, in genes in 22 glioblastomas [6]. Genes found to harbor alterations in

at least 2/22 tumors, and which had mutation frequencies of >10 mutations per Mb of DNA sequenced, were subsequently re-sequenced in an additional 83 tumors as validation. This sequencing of 22 GBM exomes, along with detection of genomic amplifications and homozygous deletions, likely identifies the majority of the mutated genes driving tumor formation and progression in glioblastoma.

One challenge has been to identify the genetic alterations that occur during tumor development that are functionally involved in driving tumor formation and progression. Carter et al developed the Cancer-specific High-throughput Annotation of Somatic Mutations (CHASM) program to systematically identify mutations in tumors that are likely to drive the cancer phenotype [7]. The CHASM program utilizes 49 predictive features to estimate the likelihood that a specific mutation in question is a driver, rather than a passenger mutation [7]. This group applied CHASM to a list of 607 missense mutations found by Parsons et al in GBM [6, 7]. The

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email